Global Organ Transplantation Market Growth (Status and Outlook) 2023-2029

Global Organ Transplantation Market Growth (Status and Outlook) 2023-2029

Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.

LPI (LP Information)' newest research report, the “Organ Transplantation Industry Forecast” looks at past sales and reviews total world Organ Transplantation sales in 2022, providing a comprehensive analysis by region and market sector of projected Organ Transplantation sales for 2023 through 2029. With Organ Transplantation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Organ Transplantation industry.

This Insight Report provides a comprehensive analysis of the global Organ Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Organ Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Organ Transplantation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organ Transplantation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organ Transplantation.

The global Organ Transplantation market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Organs that have been successfully transplanted include the heart, kidneys, brain, liver, lungs, pancreas, intestine, and thymus. From year 2000 and forward, there has been approximately 2,200 lung transplants performed each year worldwide. From between 2000 and 2006, the median survival period for lung transplant patients has been 5-and-a-half years, meaning half the patients survived for a shorter time period and half survived for a longer period. In China, a kidney transplant operation runs for around $70,000, liver for $160,000, and heart for $120,000. Although these prices are still unattainable to the poor, compared to the fees of the United States, where a kidney transplant may demand $100,000, a liver $250,000, and a heart $860,000, Chinese prices have made China a major provider of organs and transplantation surgeries to other countries. In India, a kidney transplant operation runs for around as low as $5000.

This report presents a comprehensive overview, market shares, and growth opportunities of Organ Transplantation market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Autograft
Allograft
Others

Segmentation by application
Hospital
Transplant Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Terumo
Roche
Astellas Pharma
Preservation Solutions
Transmedic
Pfizer
Sanofi
Veloxis Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.